0J1R.L - HCA Healthcare, Inc.
| Chiusura precedente | 268,36 |
| Aperto | 0,00 |
| Denaro | 0,00 x 0 |
| Lettera | 0,00 x 0 |
| Min-Max giorno | 0,00 - 0,00 |
| Intervallo di 52 settimane | |
| Volume | |
| Media Volume | 3.097 |
| Capitalizzazione | 943,219M |
| Beta (5 anni mensile) | 1,65 |
| Rapporto PE (ttm) | 0,13 |
| EPS (ttm) | 21,29 |
| Prossima data utili | 20 lug 2023 - 24 lug 2023 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireAugmedix Announces Partnership with HCA Healthcare to Accelerate the Development of AI-enabled Ambient Documentation
SAN FRANCISCO, April 20, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation, today announced a partnership with HCA Healthcare, Inc. (NYSE: HCA), one of the nation's leading healthcare providers, to accelerate development of technology that aims to transform the way patient care is documented in the acute care setting. Augmedix will collaborate with HCA Healthcare to advance the development of AI-powered
- GlobeNewswire
Augmedix Secures Strategic Financing from HCA Healthcare and Redmile Group
Company raises $12 million of new equity from HCA Healthcare and Redmile Group;Augmedix and HCA Healthcare to collaborate on AI-powered ambient documentation products for the acute care setting;Provides sufficient capital to achieve cash flow sustainability SAN FRANCISCO, April 20, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedi